跳至主要内容
临床试验/NCT04329442
NCT04329442撤回不适用

Point of Care PrEP Delivery for Young Black/African American Men Who Have Sex With Men and Young Transgender Women at High Risk for HIV Infection

University of Chicago0 个研究点开始时间: 2020年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
撤回
主要终点
Intention to Continue PrEP

研究概览

简要总结

The investigators will pilot-test an accelerated PrEP initiation approach among young high-risk Black/African American (B/AA) men who have sex with men (MSM) and transgender women (YMSM/TW) at the point of care in community contexts.

详细描述

The study team will provide a free 30-day supply of HIV pre-exposure prophylaxis (PrEP) to young Black MSM and TW identified as PrEP-eligible and interested in taking PrEP to reduce their risk of HIV acquisition. This intervention is intended to assist youth at high risk for HIV acquisition in successfully initiating PrEP use.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 24 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • ages 18-24;
  • assigned male at birth, identify as a man (cisgender), transgender woman, or gender non-conforming or genderqueer;
  • identifying as Black, African American, or multiracial with at least one parent identifying as Black or African American;
  • not currently taking PrEP or attending a visit to initiate PrEP;
  • self-report being HIV-negative;
  • reporting one of the following HIV risks in the last 6 months (Hosek, Rudy et al. 2015, Hosek, Rudy et al. 2017): a. condomless anal intercourse with an HIV-infected male partner or a male partner of unknown HIV status; b. anal intercourse with 3 or more male sex partners; c. exchange of money, gifts, shelter, or drugs for anal sex with a male partner; d. sex with a male partner and has had a sexually transmitted infection; e. sexual partner of an HIV-infected male with whom condoms were not consistently used; f. anal intercourse where the condom broke or slipped off

排除标准

  • We are excluding those individuals who were assigned female at birth (female birth certificate) and/or cis-gender women (those assigned female at birth and identify as women) from the all phases of this study as this study is intended to explore the HIV prevention behaviors of B/AA young men who have sex with men and young transgender women (assigned male at birth) as these two groups represent the highest risk groups for HIV infection in the US, yet only a small percentage are aware or currently use PrEP for HIV prevention.

研究组 & 干预措施

PrEP Received

Experimental

Participants will be provided with a free 30-day supply of PrEP.

干预措施: Emtricitabine / Tenofovir Disoproxil Oral Tablet (Drug)

结局指标

主要结局

Intention to Continue PrEP

时间窗: Post Intervention (4 months after receiving intervention)

Intention to continue use of PrEP will be assessed via survey questions related to a respondent having made a follow-up appointment to continue taking PrEP, attended an appointment to continue taking PrEP, having filled a prescription for PrEP, and reporting an interest in continuing PrEP after current supply is complete.

PrEP Adherence

时间窗: Post Intervention (4 months after receiving intervention)

PrEP adherence will be assessed via self-report of how many pills from the initial intervention remain and a self-assessment of success at remembering to take PrEP daily.

次要结局

  • PrEP Adherence Self-Efficacy(Post Intervention (4 months after receiving intervention))

研究者

申办方类型
Other
责任方
Sponsor

相似试验